Evidence map›Paper›PMID 39962130›Full record

ArticleScientific reports2025

Heteroatom-embedded Mellitic Triimido COFs for efficient proton conduction.

Keiichiro Maegawa, Mateusz Wlazło, Vellaichamy Joseph, Krzysztof Łyczko, Yaroslav Korol, Marek J Potrzebowski, Atsunori Matsuda, Atsushi Nagai

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keiichiro MaegawaNext-Generation Energy Systems group, Centre of Excellence ENSEMBLE3 sp. z o.o, Wólczyńska 133, Warsaw, 01-919, Poland.
Mateusz WlazłoChemical and Biological Systems Simulation Lab, Centre of New Technologies, University of Warsaw, Stefana Banacha 2c, Warsaw, 02-097, Poland.
Vellaichamy JosephNext-Generation Energy Systems group, Centre of Excellence ENSEMBLE3 sp. z o.o, Wólczyńska 133, Warsaw, 01-919, Poland.
Krzysztof ŁyczkoInstitute of Nuclear Chemistry and Technology, Dorodna 16, Warsaw, 03-195, Poland.
Yaroslav KorolCentre of Excellence ENSEMBLE3 sp. z o.o, Wólczyńska 133, Warsaw, 01-919, Poland.
Marek J PotrzebowskiCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza, Łódź, 112, 90-363, Poland.
Atsunori MatsudaDepartment of Electrical and Electronic Information Engineering, Toyohashi University of Technology, 1-1 Hibarigaoka, Tempaku-cho, Toyohashi, 441-8580, Aichi, Japan.
Atsushi NagaiNext-Generation Energy Systems group, Centre of Excellence ENSEMBLE3 sp. z o.o, Wólczyńska 133, Warsaw, 01-919, Poland. atsushi.nagai@ensemble3.eu.

Funding

Japan Society for the Promotion of Science 22KJ1630Toyohashi University of Technology Start-up Creation Research Grant 20222001C4
6 · The paper itself

Abstract

Ionic covalent organic frameworks (iCOFs) are promising materials for energy storage devices due to their ionic functional groups, which facilitate ion transport, and their highly ordered pores of their frameworks, which provide ideal pathways for long-term ion transport under harsh electrochemical conditions. In this study, we attempted for the first time to synthesize an unprecedented iCOF using a heteroatom-embedded mellitic triimido COF framework that enables practical ion channels on the Angstrom scale. This iCOF was subsequently evaluated as an anhydrous proton-conducting material. The heterocyclic pyridine group of the 2,5-diaminopyridine (DAPy) linker plays an important role, not only as an AB stacking-inducing group but also as a proton acceptor that interacts with impregnated H

Indexed as

Covalent organic frameworksProton conducting materialsTriimido COF

Identifiers

PMID39962130
PMCPMC11833120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.